At 12:30 IST, the barometer index, the S&P BSE Sensex, tumbled 813.63 points or 1.02% to 79,251.53. The Nifty 50 index dropped 278.15 points or 1.14% to 24,121.25.
Posts in category Business Standard
Rane Brake Lining standalone net profit rises 15.33% in the September 2024 quarter (25-10-2024)
Sales rise 9.87% to Rs 173.63 crore
Apollo Micro Systems consolidated net profit rises 139.33% in the September 2024 quarter (25-10-2024)
Sales rise 84.39% to Rs 160.71 crore
Axis Bank share price bucks weak market trend, rally 3%, here’s why (25-10-2024)
The Bank has received the RBI’s approval for the re-appointment of Amitabh Chaudhry as the MD & CEO for another 3-year term
Rs 98k-cr selloff by FIIs in Oct drags Mid, SmallCap indices 9% in 7 days (25-10-2024)
FIIs have offloaded Indian equities worth a total of Rs 98,086 crore on the stock exchanges till October 24, data from NSDL showed
Salona Cotspin Ltd leads gainers in ‘B’ group (25-10-2024)
Timex Group India Ltd, Tainwala Chemicals & Plastics (India) Ltd, G G Engineering Ltd and AGI Infra Ltd are among the other gainers in the BSE’s ‘B’ group today, 25 October 2024.
Bikaji Foods edges higher after Q2 PAT rises 15% YoY amid inflationary pressures (25-10-2024)
Bikaji Foods International added 3.97% to Rs 869 after the company reported 14.7% rise in net profit to Rs 68.6 crore on a 26% increase in total revenue from operations to Rs 721.2 crore in Q2 FY25 over Q2 FY24.
RR Kabel slides as Q2 PAT tumbles 33% YoY to Rs 49 cr (25-10-2024)
RR Kabel slipped 3.77% to Rs 1,545.65 after the company’s consolidated net profit declined 33.16% to Rs 49.52 crore in Q2 FY25 as against Rs 74.09 crore posted in Q2 FY24.
Aster DM, Laurus Labs among 5 smallcap stock ideas in a falling market (25-10-2024)
Eris Lifesciences, BLS International and Five-Star Business are the other 3 smallcap stocks that look favourably placed on the technical charts in an otherwise weak market.
Sun Pharma Q2 Preview: Profit may rise by 19%, R&D spends to impact margins (25-10-2024)
Analysts expect Sun Pharma to register double digit growth in the topline and bottomline driven by specialty sales